Small Font Regular Font Large Font
Print This Page

March 2009


Subscribe

Support Our Research

Make an Appointment

From the Director

David Valle

Welcome to the inaugural issue of our new quarterly newsletter. We’ve launched Genetics News to share with you the many ways our entire faculty and staff are turning challenging times into exciting opportunities. Read more.

Research News

New Hope for Cancer Comes Straight From the Heart Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today. In the Dec. 16 issue of the Proceedings of the National Academy of Sciences, Gregg Semenza and colleagues report that this same class of drugs may hold new promise as a treatment for cancer. This finding emerged through a search for existing drugs that might slow or stop cancer progression. Read more.

New Schizophrenia Gene Schizophrenia is a varied condition with a number of symptoms not shared by all affected. This could be one reason why it’s been difficult to identify genes that contribute to the condition. Now, David Valle, Dimitri Avramopoulos and colleagues are one gene closer to understanding schizophrenia and related disorders. Reporting in the Jan. 9 issue of the American Journal of Human Genetics, the team describes how a variation in the neuregulin 3 gene influences delusions associated with schizophrenia. Read more.

New Meaning of ‘Family’ Who we are and where we come from traditionally is defined by our family tree. But advances in technology have revealed that our history—encoded in our DNA—may not be as clear cut. In an essay in the Jan. 22 issue of Nature, Aravinda Chakravarti argues that our current perceptions of family, population and race might need revising as we enter the age of personal genomics.

Why Chemotherapy Drugs Work The anthracycline class of chemotherapeutics — doxorubicin (Adriamycin), daunorubicin, epirubicin, idarubicin — have been used for four decades to treat many types of cancer, including leukemia, lymphoma, sarcomas and carcinomas. Now, Gregg Semenza and colleagues have discovered that these drugs can keep cancer growth at bay by preventing the growth of new blood vessels. Their findings, reported online Jan. 23 at the Proceedings of the National Academy of Sciences, suggest that a subgroup of cancer patients might particularly benefit from these drugs. Read more

News from the McKusick-Nathans Institute of Genetic Medicine

Volume 1, Issue 1 – March 2009

Optimized for viewing in HTML
This and past issues can be found online here.


Top Stories

Individualized Medicine Comes to Johns Hopkins

Ice cream flavors

Picture every one of the 6 billion people on this planet shimmying all their 46 tightly packed bundles of DNA – containing 20,500 genes – into “average-sized” jeans, one-size-fits all.

Imagine vanilla ice cream only.  No pistachio, butter pecan or Cherry Garcia. 

It’s neither a pretty thought nor a tasty proposition. That’s because, despite being remarkably similar on a genetic level – in fact, the genomes of any two people are more than 99 percent the same – each recalcitrant one of us remains unique. Even a tiny fraction of variation between the three billion DNA letters that make up one’s genome and that of another can account for the difference between being an XS or an XL; between a penchant for peanuts and a life-threatening allergic reaction to them.

These slight genetic variations – most of which have little or no impact, but some of which have huge implications – imply that every one of us – each a collection of 100 trillion cells – has his or her own “flavor of health or disease,” observes David Valle, M.D., director of the Johns Hopkins McKusick-Nathans Institute of Genetic Medicine.

And yet, physicians practice what Valle calls “average” medicine; average not in sense of “mediocre” but standard.  One-flavor-fits-all. Read more.

Meet a Scientist: Akhilesh Pandey on Discoveries, Databases and the Sociology of Science

Akhilesh Pandey

Q: A major focus of your work is to find biomarkers for cancers – molecules in the bloodstream that allow for early detection.   What’s the best way to go about this daunting task?

Pandey: The field is still not settled about what is the best way to find biomarkers.  The issue is, do we need to find more markers or can we benefit  from the already-published reports  out there that no one is paying attention to?  In my lab, we are experimentalists and also do bioinformatics.  Our attitude is that these two paths are not mutually exclusive:  that of discovering new markers and re-exploring old ones that haven’t yet been sorted out as good or bad.  Read more.

Victor A. McKusick Papers Now Online

Victor McKusick

As part of its Profiles in Science project, the National Library of Medicine has collaborated with Hopkins’ Alan Mason Chesney Medical Archives to digitize and make available over the World Wide Web a selection of the Victor A. McKusick Papers for use by educators and researchers. This site provides access to the portions of the papers that have been selected for digitization.

Edmond A. “Tony” Murphy 1925-2009

Edmond "Tony" Murphy

Edmond Anthony “Tony” Murphy, M.D., former professor of medicine and chief of medical genetics at the Johns Hopkins University School of Medicine, died in January. He was 83.

Born in Swansea, Glamorganshire in Wales, U.K., Murphy received his medical training at Queen’s University in Belfast. He came to Johns Hopkins as a clinical fellow in 1956, and became a full professor of medicine in 1974, holding joint appointments in the departments of biology and biostatistics and epidemiology. Chief of medical genetics from 1974 to 1985, Murphy worked in the Moore Clinic and was a long-time colleague of the late Victor A. McKusick, founder of the field of medical genetics, who died last year.

Murphy is remembered for his wry sense of humor, magnetic personality and gentle retiring nature.

Having received an Sc.D. in biostatistics from the Johns Hopkins University in 1964, Murphy also was a mathematician and philosopher who wrote six books on topics ranging from the logic of medicine to biostatistics. Often described as a polymath, Murphy brought discussions of a wide range of ideas and topics to his classes and is remembered as a favorite teacher by many.

Murphy retired to Spain in 1994 and is survived by a niece and nephew, with whom he lived outside Barcelona.



© 2009 McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, 733 North Broadway, Baltimore, MD 21205 http://www.hopkinsmedicine.org/geneticmedicine/

For questions or more information about this newsletter, please contact the Editor.

To unsubscribe, click here, or send a blank email to sympa@lists.johnshopkins.edu with subject line: unsubscribe jhmgeneticsnews.

Questions about your subscription? Please contact the list manager.

Return to main Genetics News page.

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System, All rights reserved.

About Johns Hopkins Medicine | Patient Care | Education | Research | Health Information Library
Get Directions | Contact Us | Request an Appointment | Refer a Patient | Find a Doctor | Media Inquiries